Mycophenolate mofetil: A new immunosuppressive approach - Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection

European Neurology

Volumn 46, Issue 1, 2001, Pages 53-54

  Caponnetto, C ^a,c   Rossi, E ^b   Primavera, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Department of Neurological Sciences and Vision ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; FEMALE; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYASTHENIA GRAVIS; MYCOPHENOLIC ACID; SYNDROME;

EID: 0034960370     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050759     Document Type: Article

References (11)

1. Mycophenolate mofetil
2. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial
3. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
4. Mycophenolate is effective in the treatment of pemphigus vulgaris
5. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil
6. Treatment of myasthenia gravis with mycophenolate mofetil: A case report
7. Incomplete lupus erythematosus
8. Treatment of chronic hepatitis C with amantadine
9. Hepatitis C virus infection and autoimmunity
10. Development of myasthenia gravis after interferon alpha therapy
11. Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil